Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Molecular impacts of Meier–Gorlin syndrome mutations on human origin licensing

Journal of Biological Chemistry(2025)10.1016/j.jbc.2025.111100Source: DataRank Database

Molecular impacts of Meier–Gorlin syndrome mutations on human origin licensing is a research paper published in Journal of Biological Chemistry (2025). On theSindex it has a DataRank of 0. It has been cited 2 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access2 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)OA: gold

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Olivia Hunker ORCID,Jenna Kim,Franziska Bleichert ORCID,Ran Yang ORCID

Live enrichment

NIH NCI

Grant: F31-CA278331

NIH NIGMS

Grant: R01-GM141313

NIH NIGMS

Grant: R35GM158287

goldLicense: cc-by

publisherhttps://www.jbc.org/article/S0021-9258(25)02952-7/pdf

publisherhttps://api.elsevier.com/content/article/PII:S0021925825029527?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0021925825029527?httpAccept=text/plain

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC12830165/